A timely (and surprisingly readable) scientific journal article about TAVR in the US. The review includes details on currently FDA approved TAVR devices as well as up-and-coming investigational devices. There is a small, but positive, write-up of Anteris’ DurAVR device. The article is open access and the PDF can be located here.
Another article about trends in TAVR and SAVR. Nil funding for article with authors having COI with Anteris. DurAVR clearly on the radar as a product with the potential solution to current concerns: